Dupilumab-Related Ocular Disease: Unravelling the Link

Ocular surface disease may be present at baseline in patients with AD treated with dupilumab.

Related Keywords

Montreal ,Quebec ,Canada ,Netherlands ,Utrecht ,Melinda Gooderham ,Roselie Achten ,Vivian Shi ,Sanofi Genzyme ,Skin Centre For Dermatology ,Atopic Dermatitis At University Medical Center Utrecht ,National Expertise Center ,Queens University ,Peterborough Regional Health Centre ,International Society Of Atopic Dermatitis ,Department Of Dermatology ,University Of Arkansas ,International Society ,Atopic Dermatitis ,University Medical Center Utrecht ,Eczema Area ,Severity Index ,Utrecht Ophthalmic Inflammatory ,Medical Sciences ,Medscape Medical ,Medical Director ,Presented October ,Dermatitis ,Adverse Effects ,Side Effects ,Allergic Conjunctivitis ,Asthma ,Sthmatic ,Conjunctivitis ,Corneal Disease ,Eczema ,Internship ,Interns ,Laceration ,Ocular Allergies ,Llergic Eye Diseases ,Llergic Ophthalmologic Conditions ,Patient Safety ,Severity Indices ,Wound Management ,